Day One Biopharmaceuticals, Inc. (DAWN) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts DAWN Hot Sheet
Join SI Premium – FREE
Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) reported Q1 EPS of ($0.72), $0.07 worse than the analyst estimate of ($0.65).
For earnings history and earnings-related data on Day One Biopharmaceuticals, Inc. (DAWN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Flexsteel (FLXS) Tops Q4 EPS by 24c, Beats on Revenue; Offers Q1 Revenue Guidance
- CalPrivate Bank names Andra Frazier as chief credit officer
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
